Table 3 Sample of patients with dementia subdivided according to anti-dementia drugs
Dementia | Patients | Anti-dementia drugs 1 | |||||
|---|---|---|---|---|---|---|---|
| Â | Â | Total | Cholinesterase inhibitors | Memantine | Ginkgo biloba | ||
| Â | Â | Â | Donepezil | Rivastigmine | Galantamine | Â | Â |
| Â | N | [n (%)] | [n (%)] | [n (%)] | [n (%)] | [n (%)] | [n (%)] |
Dementia in Alzheimer's disease | 60 | 34 (56.7) | 13 (21.7) | 3 (5.0) | 7 (11.7) | 15 (25.0) | 12 (20.0) |
Vascular dementia | 145 | 26 (17.9) | 1 (0.7) | - | 1 (0.7) | 1 (0.7) | 23 (15.9) |
Dementia in Parkinson's disease | 42 | 8 (19.0) | 1 (2.4) | 1 (2.4) | 1 (2.4) | 2 (4.8) | 5 (11.9) |
Unspecified dementia | 330 | 80 (24.2) | 14 (4.2) | 4 (1.2) | 1 (0.3) | 14 (4.2) | 59 (17.9) |
Total | 577 | 148 (25.6) | 29 (5.0) | 8 (1.4) | 10 (1.7) | 32 (5.5) | 99 (17.2) |